Optimal Strategy for Repair of Type A Acute Aortic Dissection
Launched by CENTRE CARDIOLOGIQUE DU NORD · Jun 20, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The target population enrolled in the registry includes patients with TAAAD.The high volume of patients that will be enrolled in this registry will receive proximal and distal aortic repair in elective, urgent or emergency clinical condition. Efforts of investigators will be concentrated in TAAAD repair using a conservative approach of root preservation and hemiarch reconstruction in the majority of patients who will be referred in critical clinical condition. High-risk patients with older age or more comorbidities had more conservative repairs to limit surgical insult to these complicated ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • TAAD or intramural hematoma involving the ascending aorta
- • Patients aged \> 18 years
- • Symptoms started within 7 days from surgery
- • Primary surgical repair of acute TAAD
- • Any other major cardiac surgical procedure concomitant with surgery for TAAD.
- Exclusion Criteria:
- • Patients aged \< 18 years
- • Onset of symptoms \> 7 days from surgery
- • Prior procedure for TAAD
- • Concomitant endocarditis;
- • TAAD secondary to blunt or penetrating chest trauma.
About Centre Cardiologique Du Nord
Centre Cardiologique du Nord is a leading cardiac care institution dedicated to advancing cardiovascular health through innovative research and clinical excellence. With a focus on patient-centered care, the center actively participates in clinical trials to evaluate new therapies and interventions aimed at improving heart health outcomes. Leveraging a multidisciplinary team of experienced cardiologists, researchers, and healthcare professionals, the Centre Cardiologique du Nord is committed to contributing to the global medical community's understanding of cardiovascular diseases while ensuring the highest standards of patient safety and ethical practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Denis, , France
Patients applied
Trial Officials
Francesco Nappi
Principal Investigator
Cardiac Surgery Centre Cardiologique du Nord de Saint-Denis, Paris, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported